Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 395

1.

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR; International Meta-Analysis of HIV Host Genetics..

Ann Intern Med. 2001 Nov 6;135(9):782-95.

PMID:
11694103
2.

Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.

Geskus RB, Meyer L, Hubert JB, Schuitemaker H, Berkhout B, Rouzioux C, Theodorou ID, Delfraissy JF, Prins M, Coutinho RA.

J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):321-6.

PMID:
15980693
3.

Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.

Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS; International Meta-Analysis of HIV Host Genetics..

AIDS. 2003 Feb 14;17(3):377-87.

PMID:
12556692
4.

Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.

Verma R, Gupta RB, Singh K, Bhasin R, Anand Shukla A, Chauhan SS, Luthra K.

J Clin Virol. 2007 Mar;38(3):198-203. Epub 2007 Jan 19.

PMID:
17240189
5.

Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India.

Ramana GV, Vasanthi A, Khaja M, Su B, Govindaiah V, Jin L, Singh L, Chakraborty R.

J Genet. 2001 Dec;80(3):137-40.

6.

[Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].

Wasik TJ, Smoleń J, Kruszyński P, Bratosiewicz-Wasik J, Beniowski M.

Wiad Lek. 2005;58(9-10):500-7. Polish.

PMID:
16529059
7.

Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.

Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, Goedert JJ, De Rossi A, Espanol T, Frenkel L, Mayaux MJ, Newell ML, Pahwa SG, Rousseau C, Scarlatti G, Sei S, Sen L, O'Brien TR; HIV Host Genetics International Meta-Analysis Group..

AIDS. 2003 Jul 25;17(11):1631-8.

PMID:
12853745
8.

Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.

Apostolakis S, Baritaki S, Krambovitis E, Spandidos DA.

J Clin Virol. 2005 Dec;34(4):310-4.

PMID:
16286055
9.

[Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China].

Wang F, Jin L, Lei Z, Shi H, Hong W, Xu D, Shi M, Jiang J, Wang Y, Zhang B, Liu M, Li Y.

Zhonghua Liu Xing Bing Xue Za Zhi. 2000 Aug;21(4):256-60. Chinese.

PMID:
11860793
10.

Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals.

Mazzucchelli R, Corvasce S, Violin M, Riva C, Bianchi R, Dehò L, Velleca R, Cibella J, Bada M, Moroni M, Galli M, Balotta C.

J Biol Regul Homeost Agents. 2001 Jul-Sep;15(3):265-71.

PMID:
11693435
11.

Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3'A in pediatric HIV-1 infection.

Mangano A, Kopka J, Batalla M, Bologna R, Sen L.

J Acquir Immune Defic Syndr. 2000 Jan 1;23(1):52-7.

PMID:
10708056
12.

Distribution of CCR2-64I and SDF1-3'A alleles and HIV status in 7 ethnic populations of Cameroon.

Ma L, Marmor M, Zhong P, Ewane L, Su B, Nyambi P.

J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):89-95.

PMID:
16123688
13.

Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3'A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups.

Wang FS, Hong WG, Cao Y, Liu MX, Jin L, Hu LP, Wang Z, Feng TJ, Hou J, Zhang B, Shi M, Xu DP, Lei ZY, Wang B, Liu ZD, Ye JJ, Peng L, Qiu Y, Winkler C.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):124-30.

PMID:
12571520
14.

Genetic acceleration of AIDS progression by a promoter variant of CCR5.

Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, Carrington M.

Science. 1998 Dec 4;282(5395):1907-11.

15.

Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.

Sei S, Boler AM, Nguyen GT, Stewart SK, Yang QE, Edgerly M, Wood LV, Brouwers P, Venzon DJ.

AIDS. 2001 Jul 27;15(11):1343-52.

PMID:
11504955
16.

Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.

Tan XH, Zhang JY, Di CH, Hu AR, Yang L, Qu S, Zhao RL, Yang PR, Guo SX.

Infect Genet Evol. 2010 Mar;10(2):268-72. doi: 10.1016/j.meegid.2009.11.015. Epub 2009 Dec 1.

PMID:
19958843
17.

Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ.

Science. 1997 Aug 15;277(5328):959-65.

18.

Distribution of two HIV-1-resistant polymorphisms (SDF1-3'A and CCR2-64I alleles) in the Polish population.

Lewandowska M, Franciszkiewicz K, Prokop J, Ofori H, Jagodzinski PP.

J Hum Genet. 2002;47(11):585-9.

PMID:
12436194
19.

Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression.

Hendel H, Hénon N, Lebuanec H, Lachgar A, Poncelet H, Caillat-Zucman S, Winkler CA, Smith MW, Kenefic L, O'Brien S, Lu W, Andrieu JM, Zagury D, Schächter F, Rappaport J, Zagury JF.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):381-6.

PMID:
9833747
20.

CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy.

Passam AM, Zafiropoulos A, Miyakis S, Zagoreos I, Stavrianeas NG, Krambovitis E, Spandidos DA.

J Clin Virol. 2005 Dec;34(4):302-9.

PMID:
16286054

Supplemental Content

Support Center